By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company HAVN Life Sciences Inc.

HAVN Life Sciences Inc. (HAVLF)

OTC Market Data in USD, Fundamentals in CAD
$0.01
+$0.01
+900.00%
Last Update: 29 Aug 2025, 00:00
$2.79M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.00 - $0.01
52 Week Range

HAVLF Stock Price Chart

Explore HAVN Life Sciences Inc. interactive price chart. Choose custom timeframes to analyze HAVLF price movements and trends.

HAVLF Company Profile

Discover essential business fundamentals and corporate details for HAVN Life Sciences Inc. (HAVLF) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

8 Jan 2021

Employees

6.00

CEO

Tim Moore

Description

HAVN Life Sciences Inc., a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The Company also focuses on developing methodologies for the standardize and quality-controlled extraction of psychoactive compounds from plants and fungi, including Psilocybe spp. mushrooms; and the genera directive compounds, such as psilocybin, psilocin, and baeocystin, as well as the development of natural health care products from non-regulated compounds. The company was incorporated in 2020 and is headquartered in Richmond, Canada.

HAVLF Financial Timeline

Browse a chronological timeline of HAVN Life Sciences Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 2 Aug 2024

Earnings released on 30 Jul 2024

Earnings released on 19 Apr 2024

Earnings released on 15 Jan 2024

Earnings released on 30 Oct 2023

Earnings released on 2 Aug 2023

Earnings released on 31 Jan 2023

EPS came in at -$0.05 , while revenue for the quarter reached -$9.03K .

Earnings released on 31 Oct 2022

EPS came in at -$0.30 , while revenue for the quarter reached $230.76K .

Stock split effective on 3 Aug 2022

Shares were split 1 : 30 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 31 Jul 2022

EPS came in at -$21.08 , while revenue for the quarter reached $52.92K .

Earnings released on 30 Apr 2022

EPS came in at -$1.85 , while revenue for the quarter reached $168.59K .

Earnings released on 31 Jan 2022

EPS came in at -$0.41 , while revenue for the quarter reached $18.14K .

Earnings released on 31 Oct 2021

EPS came in at -$1.15 , while revenue for the quarter reached $22.39K .

Earnings released on 31 Jul 2021

EPS came in at -$18.10 , while revenue for the quarter reached $7.49K .

Earnings released on 30 Apr 2021

EPS came in at -$2.49 .

Earnings released on 31 Jan 2021

EPS came in at -$4.02 .

Earnings released on 31 Oct 2020

EPS came in at -$2.52 .

HAVLF Stock Performance

Access detailed HAVLF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run